One of the stocks which managed to emerge as a major gainer on Tuesday was the Therapeutic Solutions International (OTCMKTS:TSOI) stock. The stock was in major focus yesterday and ended up with gains of as much as 30% amidst heavy interest.
Trading Data
On Tuesday, TSOI stock increased 30.21% to $0.0153 with more than 8.06 million shares, compared to its average volume of 4.30 million shares. The stock moved within a range of $0.0115 – 0.0161 after opening trade at $0.0115.
Therapeutic Solutions International Secures Financing to Complete Current Phase III Stem Cell Clinical Trial
While it is true that there was no news about the company yesterday that may triggered the rally, it should be noted that back on September 20 the company had in fact made a major announcement. Therapeutic Solutions announced at the time that it had gone into an agreement with the firm GHS Investments LLC for the purchase of its registered shares for a sum of a maximum of $10 million.
GHS is one of the better known names in the management and investment industries and is involved in providing financial support to small cap companies for potentially high returns. As it happens, GHS has already made a range of investments and reaped rewards through its investments in a number of nano-market cap companies.
The financing is going to help Therapeutic Solutions in speeding up the Phase III clinical trial of its product JadiCells, noted Timothy Dixon, the Chief Executive Officer and President of the company.
Key Quote
“This financing will allow the acceleration of our current Phase III clinical trial assessing efficacy of JadiCells, a novel adult stem cell, for treatment of COVID-19 associated lung injury,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “The implications of this trial are far-reaching in that success will open the door for entry into other pulmonary indications including ‘long COVID’ which remains a significant health problem.”
Technical Data
TSOI stock is trading above the 20-Day and 50-Day Moving averages of $0.0124 and $0.0156 respectively. However, the stock is trading below the 200-Day moving average of $0.0217.
